0001225208-20-007831.txt : 20200515 0001225208-20-007831.hdr.sgml : 20200515 20200515163459 ACCESSION NUMBER: 0001225208-20-007831 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200513 FILED AS OF DATE: 20200515 DATE AS OF CHANGE: 20200515 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jacobsen Kevin B CENTRAL INDEX KEY: 0001735465 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07151 FILM NUMBER: 20886022 MAIL ADDRESS: STREET 1: 1221 BROADWAY CITY: OAKLAND STATE: CA ZIP: 94612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CLOROX CO /DE/ CENTRAL INDEX KEY: 0000021076 STANDARD INDUSTRIAL CLASSIFICATION: SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS [2842] IRS NUMBER: 310595760 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: THE CLOROX COMPANY STREET 2: 1221 BROADWAY CITY: OAKLAND STATE: CA ZIP: 94612-1888 BUSINESS PHONE: 5102717000 MAIL ADDRESS: STREET 1: P.O. BOX 24305 CITY: OAKLAND STATE: CA ZIP: 94612-1305 4 1 doc4.xml X0306 4 2020-05-13 0000021076 CLOROX CO /DE/ CLX 0001735465 Jacobsen Kevin B 1221 BROADWAY OAKLAND CA 94612-1888 1 EVP - Chief Financial Officer Common Stock 2020-05-13 4 M 0 15630.0000 89.8200 A 21452.0000 D Common Stock 2020-05-13 4 M 0 3585.0000 84.4500 A 25037.0000 D Common Stock 2020-05-13 4 S 0 3563.0000 205.4880 D 21474.0000 D Common Stock 2020-05-13 4 S 0 5419.0000 206.5359 D 16055.0000 D Common Stock 2020-05-13 4 S 0 6084.0000 207.2839 D 9971.0000 D Common Stock 40.0000 I By 401(k) Common Stock 24.0000 I By IRA Common Stock 3145.0000 I By Trust Stock Option (Right to Buy) 84.4500 2020-05-13 4 M 0 3585.0000 0.0000 D 2014-09-17 2023-09-17 Common Stock 3585.0000 0.0000 D Stock Option (Right to Buy) 89.8200 2020-05-13 4 M 0 15630.0000 0.0000 D 2015-09-17 2024-09-17 Common Stock 15630.0000 0.0000 D Transaction executed pursuant to a pre-planned trading program adopted by reporting person on February 13, 2020, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. This transaction was executed in multiple trades at prices ranging from $204.91 to $205.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $205.94 to $206.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $206.95 to $207.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Includes 84 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Includes 19 shares acquired through dividend reinvestment during the fiscal year. By Cheryl Brice, Attorney-in-Fact for 2020-05-15